14M119: Abstracts: Reproductive Issues in Rheumatic Disorders (1671–1674)

Abstract Moderator(s)

• 

  Megan Clowse, MD, MPH

  Duke University
  Chapel Hill, NC, United States

  Disclosure(s): GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Grant/Research Support (Ongoing); UCB: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Emily Littlejohn, DO, MPH

  Cleveland Clinic
  Cleveland, OH, United States

  Disclosure(s): Aurinia: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Oral abstract session.

Presentations:

• 10:30 AM – 10:40 AM Eastern Time

  Current Cervical Cancer Screening Guidelines Are Unsatisfactory for the Needs of Systemic Lupus Erythematosus Patients
  

  Presenting Author: Zehra Kazmi, MD – University of Texas Health Sciences Center San Antonio
• 10:40 AM – 10:45 AM Eastern Time

  Q&A
  
• 10:45 AM – 10:55 AM Eastern Time

  The Impact of Systemic Sclerosis (SSc) on Women’s Health Evaluated with a New SSc-specific Patient-reported Questionnaire
  

  Presenting Author: Maria Grazia Lazzaroni, MD – Spedali Civili
• 10:55 AM – 11:00 AM Eastern Time

  Q&A
  
• 11:00 AM – 11:10 AM Eastern Time

  Preconceptional NSAID Treatment Exposure Is Associated with a Significantly Longer Time-to-conception in Women with Spondyloarthritis: Analysis of the Prospective GR2 Cohort
  

  Presenting Author: SABRINA HAMROUN, MMed – Rheumatology Department, University Hospital of Cochin, Paris
• 11:10 AM – 11:15 AM Eastern Time

  Q&A
  
• 11:15 AM – 11:25 AM Eastern Time

  In Utero Exposure to Hydroxychloroquine Does Not Associate with Ocular Toxicity as Assessed by Optical Coherence Tomography Five Years After Birth
  

  Presenting Author: Peter Izmirly, MD – NYU Grossman School of Medicine
• 11:25 AM – 11:30 AM Eastern Time

  Q&A